SCHEMBL19904416

SCHEMBL19904416

CCc1cc(CCCN2CCCC2)ccc1OC1CC1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ABCB1 P08183 1/20 0.44
HRH3 Q9Y5N1 4/20 0.43
SIGMAR1 Q99720 3/20 0.43
SLC6A4 P31645 2/20 0.43
SLC6A3 Q01959 2/20 0.43
DRD2 P14416 1/20 0.43
EBP Q15125 2/20 0.43
TMEM97 Q5BJF2 1/20 0.43
HRH1 P35367 2/20 0.42
LTA4H P09960 1/20 0.42
L3MBTL3 Q96JM7 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
CHRM2 P08172 1/20 0.40
ADRA2C P18825 1/20 0.40
SLC6A2 P23975 1/20 0.40
KCNH2 Q12809 1/20 0.40
CACNA1C Q13936 1/20 0.40
SCN5A Q14524 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19904479 0.99 HRH3 (0.45) ABCB1HRH3SIGMAR1SLC6A4SLC6A3
SCHEMBL19904510 0.96 ABCB1 (0.43) ABCB1HRH3SIGMAR1SLC6A4SLC6A3
SCHEMBL19904585 0.89 SIGMAR1 (0.40) ABCB1HRH3SIGMAR1SLC6A4SLC6A3
SCHEMBL7999028 0.86 L3MBTL1 (0.51) HRH3SIGMAR1SLC6A4SLC6A3DRD2
SCHEMBL24045454 0.85 HRH1 (0.47) ABCB1HRH3SIGMAR1SLC6A4SLC6A3
SCHEMBL19043653 0.84 SIGMAR1 (0.55) ABCB1HRH3SIGMAR1EBPTMEM97
SCHEMBL21122862 0.82 ABCB1 (0.46) ABCB1HRH3SIGMAR1SLC6A4SLC6A3
SCHEMBL16595882 0.82 SLC6A4 (0.51) ABCB1HRH3SIGMAR1SLC6A4SLC6A3
SCHEMBL16595899 0.82 CSNK2A1 (0.53) HRH3SIGMAR1SLC6A4SLC6A3DRD2
SCHEMBL16695116 0.81 CSNK2A1 (0.52) HRH3SIGMAR1SLC6A4SLC6A3DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3063141-B1 N-(1-HYDROXY-3-(PYRROLIDINYL)PROPAN-2-YL)PYRROLIDINE-3-CARBOXAMIDE DERIVATIVES AS GLUCOSYLCERAMIDE SYNTHASE INHIBITORS BIOMARIN PHARM INC (US) 2018-02-28 EP disclosed